(INNS)
SUVEMCITUG(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)], HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-452) [VH (HOMO SAPIENS IGHV3-21*01 (74.7%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT [9.8.14] (26-34.52-59.98-111)) (1- 122) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, CH3 D12, L14 (CH1 K120 (219) (123-220), HINGE 1- 15 (221-235), CH2 (236-345), CH3 D12 (361), L14 (363) (346-450), CHS (451-452)) (123-452)], (225-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-219') [V-KAPPA (HOMO SAPIENS IGKV1-6*01 (85.4%) -IGKJ4*01 (100%), CDR-IMGT [8.3.12] (27-34.52-54.91-102)) (1'-112') -HOMO SAPIENS IGKC*01 (100%), KM3, A45.1 (158), V101 (196) (113'-219')]; DIMER (231-231'':234-234'')-BISDISULFIDE; PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, GLYCOFORM ALFA(WHO)
SUVEMCITUGUM(INN)